Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02650921 · ClinicalTrials.gov registry record · NA
Effectiveness and Safety of Restylane Lyft With Lidocaine in the Dorsal Hand
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT02650921 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 92 participants.
The verdict
NCT02650921, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
This is a randomized, evaluator-blind, split hand, multi-center study of the effectiveness and safety or Restylane Lyft with Lidocaine compared to no treatment for injection in the dorsal hand to correct volume deficits.
Interventions
- DEVICE Restylane Lyft with Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02650921
The ClinicalTrials.gov registry entry for NCT02650921 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Restylane Lyft with Lidocaine is the first listed.
NCT02650921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02650921 about?
NCT02650921 is a clinical study titled "Effectiveness and Safety of Restylane Lyft With Lidocaine in the Dorsal Hand". This is a randomized, evaluator-blind, split hand, multi-center study of the effectiveness and safety or Restylane Lyft with Lidocaine compared to no treatment for injection in the dorsal hand to correct volume deficits.
What is the current status of trial NCT02650921?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2015-12. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02650921?
The interventions under investigation include: Restylane Lyft with Lidocaine (DEVICE).
Who is sponsoring clinical trial NCT02650921?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.